The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
MPN Workshop of the Carolinas 2024 | The importance of early intervention in myelofibrosis
In this video, Abdulraheem Yacoub, MD, University of Kansas Medical Center, Kansas City, KS, discusses his views on early intervention in myelofibrosis (MF), highlighting that administering active therapies earlier in the disease course has the potential to significantly improve patient outcomes. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy: Novartis, CTI Pharma, Incyte, Pfizer, Acceleron Pharma, Pharmaessentia.
